It's not perfect, but it's a good start: FDA panelists largely endorse Aimmune's peanut allergy therapy
Two days after a fairly benign review from FDA staff, an independent panel of experts largely endorsed the efficacy and safety of Aimmune’s peanut …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
